Fundraising Fox

Robert Kamen

Investor

Venture Partner at Third Rock Ventures

Massachusetts

Writes $100K – $1.5M checks · typically $1.5M

Experience

  1. Self-employedRetiredcurrent2024 — present
  2. HARBOUR BIOMEDMember Board of Directorscurrent2016 — presentShanghai City, China
  3. HBM Alpha TherapeuticsMember Board of Directorscurrent2020 — presentCambridge, Massachusetts, United States
  4. EpimAb Biotherapeutics, Inc.Board Member2015 — 2025Shanghai City, China
  5. Third Rock VenturesAdvisory Partner2021 — 2024Greater Boston Area
  6. Third Rock VenturesVenture Partner2018 — 2021Boston, Massachusetts, United States
  7. Third Rock VenturesEntrepreneur In Residence2010 — 2017Boston, Massachusetts, United States
  8. Jounce TherapeuticsBoard of Directors2013 — 2023Cambridge, Massachusetts
  9. Sudbury Valley Trustees IncBoard Member2006 — 2020Sudbury, Massachusetts
  10. Neon TherapeuticsBoard Member2015 — 2020Cambridge, Masschusetts
  11. LyceraBoard of Directors2009 — 2019Ann Arbor, Michigan
  12. Harbour AntibodiesBoard Member2007 — 2016Rotterdam, Netherlands
  13. Opsonic TherapeuticsBoard of Directors2010 — 2014
  14. Velocon Sports, IncManaging Director2007 — 2014Concord, Massachusetts
  15. Anchor TherapeuticsBoard of Directors2010 — 2012Cambridge, Massachusetts
  16. GlaxoSmithKlineBiopharm Investment Board2009 — 2011
  17. BioAssets Development CorporationChairman of the Board2005 — 2010Greater Boston Area
  18. Oxford Bioscience PartnersExecutive in Residence2002 — 2008Boston
  19. Abbott Bioresearch Center, Abbott LaboratoriesPresident2001 — 2002Worcester, Massachusetts
  20. BASF Bioresearch CorporationPresident1991 — 2001Worcester, Massachusetts
  21. Massachusetts Biomedical Initiatives (MBI)Board Member1993 — 1998Worcester, MA
  22. Whitehead Institute for Biomedical ResearchVisiting Scientist1989 — 1990
  23. Genetics Institute, IncSenior VP Scientific Affairs1982 — 1989Cambridge, Massachusetts
  24. Imperial Cancer Research Fund LaboratoriesHead, Transcription Laboratory1976 — 1982London, United Kingdom

Education

  1. Harvard University Graduate School of Arts and SciencesPh.D., Biochemistry and Molecular Biology1965 — 1970
  2. Imperial Cancer Research Fund Laboratories (London)DNA Tumor Viruses1973 — 1976
  3. Universität Zürich (Switzerland)Biochemistry and Molecular Biology1970 — 1972
  4. Amherst CollegeBachelor of Arts - BA, Biophysics1961 — 1965
  5. Andrew Jackson High School (Queens, New York)1957 — 1961

Skills & more

Biotechnology45Cancer7Immunology21Drug Discovery53Lifesciences23Protein Chemistry9Molecular Biology20Clinical Development4Oncology8Biopharmaceuticals14Technology Transfer7Analytics3
+7 moreCellBiologicsInfectious DiseasesGeneticsLife SciencesDrug DevelopmentPharmaceutical Industry

From Robert's professional profile.

Deals · 3

Neon TherapeuticsBoard seat

via Third Rock Ventures · filed Dec 2017 · $106M raise

LyceraBoard seat

via Third Rock Ventures · filed Jun 2015

Jounce TherapeuticsBoard seat

via Third Rock Ventures · filed Apr 2015 · $56M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Third Rock Ventures

Abbie Celniker
Investor at Third Rock Ventures
Adam Tebbe
Investor at Third Rock Ventures
Alan Ezekowitz
Investor at Third Rock Ventures
Alison Connors
Investor at Third Rock Ventures
Amanda Chan
Investor at Third Rock Ventures
Andrea van Elsas
Investor at Third Rock Ventures
Andrew Warren
Senior Associate at Third Rock Ventures
Angelo Severino
Investor at Third Rock Ventures

Frequently asked questions

Who is Robert Kamen?
Venture Partner at Third Rock Ventures
Where does Robert Kamen work?
Robert Kamen is Venture Partner at Third Rock Ventures.
What check size does Robert Kamen write?
Robert Kamen typically writes checks of $100K – $1.5M.
What boards does Robert Kamen sit on?
Robert Kamen holds tracked board seats at Jounce Therapeutics, Lycera, Neon Therapeutics.
Where did Robert Kamen go to school?
Robert Kamen studied at Harvard University Graduate School of Arts and Sciences (Ph.D., Biochemistry and Molecular Biology); Imperial Cancer Research Fund Laboratories (London) (DNA Tumor Viruses); Universität Zürich (Switzerland) (Biochemistry and Molecular Biology).

Same school

Also attended Harvard University Graduate School of Arts and Sciences14

Danny CrichtonPartner, Research at Lux Capital, publishing the Securities newsletter and RiskgamingDavid BorcsokPartner at Mucker CapitalConnie LiPrincipal at F-Prime Capital PartnersTyler HollowayInvestor at E14 FundRyan PeerAssociate at Frazier Life SciencesErik KnallInvestment Associate at Prime Impact Fund

+ 8 more

Also attended Amherst College96

Will ReedInvestor at Spark CapitalPascual Cortes-MonroyPrincipal at NorthzoneYoni RechtmanPartner at Slow VenturesPaul GoodrichCo-Founder at Madrona Venture GroupConor DeveneyPrincipal at GreycroftPaul LevineOperating Partner at Sapphire Ventures

+ 90 more

Shared employers

Also worked at HARBOUR BIOMED1

Adam ZongEntrepreneur-In-Residence at The Innovation Space

Also worked at Third Rock Ventures78

Lisa PurcellInvestor at Third Rock VenturesPaul MeloneInvestor at Third Rock VenturesKevin MunnellyInvestor at Third Rock VenturesAmanda ChanInvestor at Third Rock VenturesJigar RaythathaInvestor at Third Rock VenturesOlie LuchitskyInvestor at Third Rock Ventures

+ 72 more

Also worked at GlaxoSmithKline111

Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Victoria TaylorInvestor at MedicxiJeb KeiperInvestor at Third Rock VenturesJane SuhPrincipal on the AlleyCorp Healthcare teamCarol SuhPartner at ARCH Venture PartnersRudina SeseriFounder and Managing Partner at Glasswing Ventures

+ 105 more

Also worked at Abbott Bioresearch Center, Abbott Laboratories40

Nick GasbarroChief of Staff at QED InvestorsManik PasrichaVice President at Titan CapitalJennifer SmoterChief Communications & Governance Officer at Takeda VenturesTakehiko SawabeDirector at Beyond Next VenturesAndrew BierDigital Pharma Advisor at Excelerate Health VenturesShwen GweeDigital Pharma Advisor at Excelerate Health Ventures

+ 34 more